Pathology Study Guide

📖 Core Concepts Pathology – scientific study of disease: causes, mechanisms, structural changes, and clinical manifestations. Main Divisions – Anatomical pathology (tissues & organs) ↔ Clinical pathology (bodily fluids & laboratory tests). Cellular Pathology – Rudolf Virchow’s principle: diseases originate at the cellular level. Germ Theory – microbes (bacteria, viruses, fungi, protozoa, prions) are primary disease agents; replaced humoral theories. Specimen Types – biopsies, surgical resections, autopsy material, blood, urine, other fluids. Key Techniques – gross examination, microscopic staining (H&E, special stains), immunohistochemistry (IHC), molecular assays (PCR, sequencing), cytology smears. Anatomical Sub‑specialties – surgical, cytopathology, dermatopathology, histopathology, neuropathology, pulmonary, renal, oral & maxillofacial. Molecular Pathology – analysis of DNA, RNA, protein; uses qPCR, multiplex PCR, microarrays, FISH, sequencing, immunofluorescence. Clinical Applications – oncology (mutation detection, therapy prediction), infectious disease (pathogen ID, resistance genes). 📌 Must Remember Pathology = disease detective; integrates structure (anatomical) and chemistry/genes (clinical & molecular). Two core branches: Anatomical (tissue‑based) vs. Clinical (fluid‑based). Virchow’s rule: “All cells originate from other cells” → disease = cellular alteration. Germ theory → microbes = primary cause of many infections; basis for microbiology‑linked pathology. Specimen checklist: biopsy → resection → autopsy → blood → urine → other fluids. Core lab toolbox: gross → fixation → embedding → sectioning → staining → microscopy; plus IHC & molecular assays. Molecular techniques: qPCR – quantifies nucleic acids. Multiplex PCR – detects several targets simultaneously. DNA microarray – screens thousands of genes. In‑situ hybridization / FISH – localizes DNA/RNA in tissue. Sequencing – determines exact nucleotide order. Oncologic use – mutation profiling → targeted‑therapy selection. Infectious‑disease use – pathogen nucleic‑acid detection; resistance‑gene identification. 🔄 Key Processes Standard Tissue Workflow Gross examination → fixation (usually formalin) → processing → paraffin embedding → microtome sectioning → staining (H&E ± special) → microscopic interpretation. Cytology Smear Workflow Sample collection (e.g., fine‑needle aspirate) → smear on slide → fixation → rapid stains (Diff‑Quik) or Papanicolaou → microscopic review. Molecular Assay Workflow Sample acquisition (tissue, blood, fluid) → nucleic‑acid extraction → amplification (PCR/RT‑PCR) → detection (fluorescence, sequencing) → result interpretation. Immunohistochemistry (IHC) Process Section preparation → antigen retrieval → primary antibody incubation → secondary antibody + chromogen → visualization of protein expression. 🔍 Key Comparisons Anatomical vs. Clinical Pathology Anatomical: tissue/organ focus; uses microscopy, IHC, molecular tissue assays. Clinical: fluid focus; uses chemistry panels, microbiology cultures, hematology, molecular fluid assays. Histopathology vs. Cytopathology Histopathology: fixed, processed tissue sections; preserves architecture. Cytopathology: free cells or small clusters; rapid, less architecture, excellent for screening (e.g., Pap smear). Molecular vs. Conventional Microscopy Molecular: detects DNA/RNA/protein signatures; high sensitivity, useful when morphology is ambiguous. Microscopy: visualizes cellular/tissue structure; essential for pattern recognition and grading. Biopsy vs. Resection Specimens Biopsy: limited tissue (core, incisional, excisional); used for diagnosis & staging. Resection: whole organ/tissue; allows assessment of margins, invasion depth, comprehensive staging. ⚠️ Common Misunderstandings “Pathology only looks at tissue.” → Clinical pathology analyzes blood, urine, CSF, etc. “Molecular pathology is only for cancer.” → It’s also vital for infectious‑disease detection and genetic disorders. “All diseases need a biopsy.” → Some (e.g., certain neurodegenerative or functional disorders) are diagnosed clinically/imaging‑wise. “Germ theory applies only to bacteria.” → Viruses, fungi, protozoa, and prions are also germ‑theory agents. “One stain works for every diagnosis.” → Special stains, IHC, and molecular assays are chosen based on the suspected pathology. 🧠 Mental Models / Intuition “Disease Detective” Model – treat every specimen as a crime scene: collect clues (gross appearance, microscopic pattern, molecular signature), piece them together, and identify the “perpetrator.” Cell‑First Principle – think of each disease as a malfunctioning “cell program”; structural changes are the visible output, molecular changes are the underlying code. Layered Analysis – start broad (gross), narrow to microscopic, then drill down to molecular/IHC when morphology is insufficient. 🚩 Exceptions & Edge Cases Prion diseases – not visible with routine stains; require specialized immunohistochemistry or electron microscopy. Fresh‑frozen tissue – needed for some molecular tests; formalin fixation can degrade nucleic acids. Non‑infectious inflammatory disorders – may lack identifiable microbes despite germ‑theory background. Certain brain tumors – diagnosed increasingly by molecular markers (e.g., IDH mutation) rather than imaging alone. 📍 When to Use Which Tissue available & architectural detail needed → Anatomical pathology (histology, IHC). Only fluid or blood available → Clinical pathology (chemistry, hematology, microbiology, fluid PCR). Rapid pathogen identification or resistance profiling → Molecular PCR/FISH on fluid or tissue. Need to know protein expression (e.g., HER2, Ki‑67) → IHC or immunofluorescence. Comprehensive tumor profiling for targeted therapy → Next‑generation sequencing or multiplex PCR panels. 👀 Patterns to Recognize Necrosis + acute inflammation → typical of bacterial infection. Keratin pearls & intercellular bridges → squamous cell carcinoma. Psammoma bodies → papillary carcinoma (thyroid, ovarian, meningioma). Granulomas with caseation → tuberculosis. Diffuse strong nuclear p53 staining → TP53 mutation in many cancers. BRAF V600E mutation → melanoma, certain colorectal cancers (guides targeted therapy). 🗂️ Exam Traps Distractor: “All cancers are staged by imaging alone.” – Wrong: pathology provides tumor size, depth, margin status, and molecular grade. Distractor: “PCR can replace all histology.” – Wrong: morphology is still essential for context; PCR only detects specific nucleic acids. Distractor: “Prions are bacteria detectable with Gram stain.” – Wrong: prions are proteinaceous infectious agents; require special assays. Distractor: “H&E stain is sufficient for all diagnoses.” – Wrong: special stains, IHC, and molecular tests are required for many entities (e.g., amyloid, melanoma). Distractor: “Viruses are always cultured for diagnosis.” – Wrong: molecular nucleic‑acid detection is often faster and more sensitive. --- Study tip: Review each bullet, then quiz yourself by converting a clinical vignette into the appropriate pathology pathway (gross → microscopy → molecular). This reinforces decision‑making and spot‑pattern skills just before the exam.